Sarcomere Gene Mutations Are Associated With Increased Cardiovascular Events in Left Ventricular Hypertrophy
Takashi Fujita(Gifu Prefectural Tajimi Hospital), Masakazu Yamagishi, Shintaro Kinugawa(Kyushu University), Noboru Fujino(Kanazawa University), Toru Kubo(Kōchi University), Masanori Asakura(National Cerebral and Cardiovascular Center), Issei Komuro(University of Tokyo Hospital), Hidekazu Ino(Kanazawa University), Masa‐aki Kawashiri(Kanazawa University), Kenshi Hayashi(Kanazawa University), Yoshinori Doi(Chikamori Hospital), Masafumi Kitakaze(Hanwa Memorial Hospital), Chuwa Tei(Kagoshima University), Ryuichiro Anan(Brigham and Women's Hospital), Hiroyuki Tsutsui(Juntendo University), Shigeki Kobayashi(Yamaguchi University), Tetsuo Konno(Kanazawa University), Masafumi Yano(Yamaguchi University)
Cited by 28
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1995|932